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Abstract
The diagnosis of mycobacterial infections has been dramatically improved by the introduction of molecular methods aimed to
reduce the time to diagnosis as compared with culture. The broad range pan-mycobacterial PCR can detect all the mycobacterial
species directly from clinical specimens. We aimed to evaluate its usefulness and its clinical added value for the diagnosis of
nontuberculous mycobacterial (NTM) infections. We performed a retrospective study (2003–2013) including 952 samples taken
from 639 patients with clinical suspicion of NTM infection. The performance of smear microscopy, PCR and culture was
established using clinical data to investigate discrepant results. We also compared the time to microbial diagnosis between the
direct PCR and culture. The sensitivity, specificity, positive and negative predictive values of the PCR were 61.6% (53.5–69.1),
99.1% (98.2–99.6), 92.8% (85.8–96.5) and 93.4% (91.6–94.9), respectively, when considering all specimens. When considering
smear-positive specimens and smear-negative specimens, the sensitivity was 81.6% and 40%, respectively. The sensitivity for
pulmonary and extra-pulmonary smear-positive specimens was 85.2% versus 72.7%. The median time to identification at species
level was 35 days (SD, 17.67) for culture and 6 days (SD, 2.67) for the PCR (when positive), which represents a 29-day shorter
time to results (p < 0.0001). The 16S rRNA gene pan-mycobacterial PCR displays a substantial benefit in terms of time to
diagnose NTM infections when compared with culture. Despite an excellent specificity, its sensitivity is yet limited in particular
for smear-negative specimens, which might be improved by relying onto real-time PCRs.
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Introduction
Nontuberculous mycobacteria (NTM), in contrast to
Mycobacterium tuberculosis complex species, are bacteria
widely spread in the environment and can be found in a broad
range of ecosystems such as soils and water, including drinking
water systems [1–3]. NTM are opportunistic pathogens associ-
ated with both pulmonary and extra-pulmonary infections de-
pending on the species. Their medical importance has recently
raised due to the increasing number of immunocompromised
hosts (solid organ transplant recipients and oncologic patients
among others) and due to the modern tools that improved their
detection in clinical sample [1, 2, 4]. While most of the NTM
are non-pathogenic, the pathogenic NTM are generally causing
pulmonary infections (90% of cases) whereas extra-pulmonary
manifestations can involve any organ and tissues, causing for
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instance lymphadenitis, skin infections, bones or soft tissue or
may be disseminated [1, 2, 4, 5].
While clinical manifestations of NTM vary according
to the species and to the route of infection (inhalation,
ingestion or inoculation), different species can lead to
similar diseases but may require distinct treatments, which
makes the microbiological diagnosis important [1, 2, 4].
Due to their structural characteristics, mycobacteria are
naturally resistant to many antibiotics and treating NTM
infections requires a prolonged treatment with a combina-
tion of multiple antimicrobial molecules, which choice is
based on the species identification and on the results of
antibiotic susceptibility testing [3, 5].
Smear-examination of clinical samples to detect acid-
fast bacilli (AFB) was historically the first microbiological
test for the diagnosis of mycobacterial infection. However,
this method has a limited sensitivity and specificity and
does not provide any hint on the mycobacterial species.
In particular, smear microscopy cannot distinguish
mycobacteria of the complex tuberculosis from NTM [6].
So far, culture represents a reference method for microbi-
ological diagnosis of mycobacteria due to a low limit of
detection (10 to 100 viable organisms per millilitre) [7].
Culture also provides a pure isolate for subsequent antimi-
crobial susceptibility testing. However, culture is affected
by the slow growth of mycobacteria especially for the so-
called slow-growing species as they need more than 7 days
to form a colony (as compared with about 48–72 h for
rapidly growing species). In addition, infections due to
some mycobacteria may not be detected by conventional
culture because of the requirement of specific nutrients
such as hemin forMycobacterium haemophilum or specific
t empe r a t u r e cu l t u r e c ond i t i o n s o f 3 0 °C fo r
My c o b a c t e r i u m ma r i n um a n d o f 4 2 ° C f o r
Mycobacterium xenopi. Finally, some mycobacteria such
as Mycobacterium leprae remain uncultivable in vitro.
During the last decades, several molecular methods
have been developed for the detection and identification
of M. tuberculosis complex and NTM directly from clin-
ical samples, in order to circumvent the slow or difficult
growth of these organisms. Molecular methods have the
potential to shorten the diagnosis from several weeks to
days or even hours. The aim of this study was to evaluate
the usefulness of a pan-mycobacterial PCR targeting the
16S rRNA–encoding gene. This PCR has the potential to
detect any mycobacterial species and when positive to
provide further identification at species (or complex) level
by Sanger sequencing of the obtained amplicon. We con-
ducted a retrospective study analysing the results of cul-
tures, smear microscopy and 16S rRNA gene PCR, over a
10-year period representing samples taken from patients
suspected to suffer from pulmonary or extra-pulmonary
infection due to nontuberculous mycobacteria.
Method
Study design
The retrospective study was conducted over a period of
10 years (2003–2013) for which a mycobacterial infection
was suspected and specimens were analysed in the
Laboratory of Molecular Diagnostic and Mycobacteria of
the Institute of Microbiology of the Lausanne University
Hospital, a 1000-bed tertiary-care hospital located in
Lausanne, Switzerland. Using the laboratory information
system (LIS) of our hospital, we achieved a comprehen-
sive extraction of all analyses corresponding to mycobac-
terial diagnostic requests between 2003 and 2013.
Samples positive for Mycobacterium tuberculosis com-
plex and patients for which clinical data were not avail-
able were excluded. This resulted to the inclusion of 952
specimens corresponding to 639 patients (Fig. 1).
We performed an analysis (i) “per sample” to establish
the analytical performance (sensitivity, specificity, posi-
tive and negative predictive values) of the pan-
mycobacterial PCR, considering culture and clinical data
as the gold standard and (ii) “per patient” to establish the
time to microbiological diagnostic for the pan-
mycobacterial PCR and culture. To assess the perfor-
mance of the direct pan-mycobacterial PCR, we used first
culture, then clinical data as reference, an approach that
we previously applied to determine the performance of
M. tuberculosis rapid molecular tests (Table S1) [6, 8].
In particular, specimens with positive PCR and negative
culture were considered true positive (i) if the same spec-
imen had a positive smear microscopy; (ii) if another
specimen of the same patient had a positive PCR; (iii) if
the identified NTM was a fastidious or uncultivable mi-
croorganism, namely M. genavense, M. marinum,
M. ulcerans, M. haemophilum or M. leprae; and (iv) if
based on the clinical data. For the second analysis “per
patient”, only patients with a positive NTM culture for
which the results of direct smear microscopy and pan-
mycobacterial PCR were available were included. For a
given patient, repeated infections with the same mycobac-
terial species were considered independently and included
again if more than 12 months separated both positive
PCRs. In addition, when multiple samples gave a positive
result for a given infection episode, the fastest microbio-
logical result was considered to calculate the time to
result.
Ethical issues
The study was approved by the local ethics committee
(Commission Cantonale d’Ethique de la Recherche sur
l’Etre Humain, Lausanne, Switzerland), protocol 372/13.
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Microbiology methods
Smear examination for acid-fast bacilli detection was per-
formed by staining heat-fixed samples with a fluorescent
auramine-thiazine red [6, 8, 9]. Smear grading was determined
according to the International UnionAgainst Tuberculosis and
Lung Disease scale. Solubilisation of purulent samples was
achieved using the mucolytic agent N-acetyl-L-cysteine (2%
m/v pH 6.8). For any positive direct examination for AFB, a
Mycobacterium tuberculosis–specific PCR was performed
without waiting for the result of the culture [10]. In case of
negative M. tuberculosis–specific PCR, a pan-mycobacterial
PCR was performed.
Mycobacterial cultures were achieved in Mycobacteria
Growth Indicator Tube (Becton Dickinson, Heidelberg,
Germany) after sample treatment with NaOH in order to elim-
inate bacteria that constitute the flora of non-sterile samples
and incubated for up to 8 weeks in the automated growth
detection system BACTEC MGIT 960 (Beckton Dickinson)
[9]. Culture conditions were adjusted when infection with
M. haemophilum (culture supplemented with hemin),
M. marinum (grows temperature of 30 °C) or M. xenopi
(grows temperature at 42 °C) were suspected. The presence
of mycobacteria in positive culture was determined by AFB
detection using a Ziehl-Neelsen staining; if positive, the
presence/absence of M. tuberculosis complex was evaluated
using the M. tuberculosis complex specific antigen test (BD
MGIT TBc Identification Test, Beckton Dickinson). When
negative forM. tuberculosis complex, the mycobacterial strain
was identified using pan-mycobacterial 16S rRNA gene PCR
and, when necessary, pan-mycobacterial rpoB PCR as well as
pan-mycobacterial hsp65 PCR as described below.
Pan-mycobacterial 16S rRNA gene PCR
The pan-mycobacterial PCR targets the 16S rRNA gene with
forward primers 5′-TGCACACAGGCCACAAGGGA-3′ and
reverse primers 5′-GAGAGTTTGATCCTGGCTCAG-3′ spe-
cific for the genusMycobacterium as previously reported [10,
11]. During the studied period, a nested PCR was carried to
increase the sensitivity of this method used directly on clinical
specimens. It consisted in using a second pair of primers
nested (NF 5′-CTTAACACATGCAAGTCGAAC-3′ and
NR 5′-TTTCACGAACAACGCGACAA-3′) within the first
amplification product. This significantly improves sensitivity
because of the double amplification, but the risk of contami-
nation is higher. The product of this double amplification was
then sequenced with primer 5′-CCCACTGCTGCCTC
CCGTAG-3 ′ and primer 5 ′-CTTAACACATGCAA
GTCGAAC-3′, and the obtained nucleotide signature se-
quence is compared with other signature sequences, which
allows the determination of the name of the mycobacterial
species that was amplified [11, 12].
Fig. 1 Study design and specimens distribution. The diagnostic performance of the different tests was established using clinical data to investigate
discrepant results
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Data analysis and statistics
The databases were analysed with the Stata software (Stata
Statistical Software 2011, Release 12, Stata Corporation,
College Station, TX). Median times to results were compared
using the Wilcoxon-Mann-Whitney test. A Student t test was
used to determine the independent and non-equal variances. A
p value < 0.05 was considered statistically significant.
Results
Patients and samples
Our study included 952 samples collected between 2003 and
2013 (corresponding to 639 patients) with a direct smear ex-
amination, a mycobacterial culture, and a direct 16S rRNA
gene pan-mycobacterial PCR. Three environmental speci-
mens were excluded (Fig. 1). Among the 952 specimens,
15.3% (n = 146) had a positive culture and 84.6% (n = 806)
had a negative culture (Fig. 1 and Table 1). A total of 97
specimens (10.2%) had positive direct pan-mycobacterial
PCR. Among all the species identified, either by culture or
direct pan-mycobacterial PCR, 61% were slow-growing or
39% were fast-growing mycobacteria (Fig. 2). The top five
mycobacterial species identified were M. avium complex
(30.1%), M. group abscessus-chelonae (21.2%), M. kansasii
(11.5%),M. haemophilum (11.5%) andM. genavense (4.5%).
During the studied period, an outbreak of M. haemophilum
occurred, which explains that this organism is found in the top
five (Fig. 2) [11].
Sensitivity, specificity and predictive value
of smear microscopy
Smear microscopy, which is historically the first microbiolog-
ical test, performed for the diagnosis of tuberculosis may vary
a lot in terms of sensitivity, specificity and predictive values
according to the region, to the prevalence of mycobacterial
infections and to the experimenter. We established the perfor-
mance of smear microscopy on the 952 clinical specimens
using clinical data to investigate discrepant results between
smear microscopy, pan-mycobacterial PCR and mycobacteri-
al culture (Table 1 and Table S1). The sensitivity, specificity,
PPVand NVP of the smear microscopy were 52.1% (77/146),
96.9% (780/806), 75.2% (77/102) and 91.8% (780/850).
When considering pulmonary specimens the sensitivity, spec-
ificity, PPV and NVP of the smear microscopy were 62.1%
(54/87), 95% (247/260), 80.6% (54/67) and 88.2% (247/280).
When considering extra-pulmonary specimens, the sensitivity,
specificity, PPV and NVP were 38.3% (23/60), 97.8% (533/
545), 65.7% (23/35) and 93.5% (533/570). The data suggest a
limited sensitivity and low PPVof the smear microscopy for
the detection of NTM especially for extra-pulmonary speci-
mens. The specificity and the NPVof the smear microscopy is
good. However, the NPV might have been artificially in-
creased by the low prevalence of NTM infections.
Sensitivity, specificity and predictive value
of mycobacterial culture
To address the diagnostic performance of culture, we used both
microbiological findings and clinical data as reference (Table 2
and Table S1). When considering all specimens, the sensitivity,
specificity, PPV and NPV of culture were 91.8% (134/146),
100% (806/806), 100% (134/314) and 98.5% (806/818).
When considering only pulmonary specimens, the sensitivity,
specificity, PPVand NPVof culture were 98.8% (86/87), 100%
(260/260), 100% (86/86) and 99.6% (260/261). When consid-
ering extra-pulmonary specimens, the sensitivity, specificity,
PPV and NPV of culture were 81.4% (48/59), 100% (546/
546), 100% (48/48) and 98% (546/557). Among PCR-
positive culture, negative specimens were M. leprae (n = 1),
M. genavense (n = 4) and M. marinum/ulcerans (n = 3).
Sensitivity, specificity and predictive value
of the pan-mycobacterial PCR
The global performance of the direct pan-mycobacterial PCR
for the detection of NTMs was achieved using first culture as
reference then using microbiological and clinical data as ref-
erence. When considering all the 952 clinical specimens, in-
cluding pulmonary and extra-pulmonary specimens as well as
Table 1 Performance of the smear microscopy on a total of 952 samples. PPV positive predictive value, NPV negative predictive value
Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
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smear-positive and smear-negative specimens and using clin-
ical data to investigate microbiological discrepant results, the
direct pan-mycobacterial PCR exhibited a sensitivity of
61.6% (90/146), a specificity of 99.1% (799/806), a positive
predictive value (PPV) of 92.8% (90/97) and a negative pre-
dictive value of 93.4% (799/855) (Table 3 and Table S1).
When considering only smear-positive specimens, the sensi-
tivity, specificity, PPV and NPV were 81.6% (62/76), 100%
(25/25), 100% (62/62) and 64.1% (25/39). When considering
only smear-negative specimens, the sensitivity, specificity,
PPV and NPV were 40% (29.3–51.7), 99.1% (98.2–99.6),
80% (64.1–90.0) and 94.8% (93.1–96.2) (Table 4).
When considering only pulmonary specimens, the sensitiv-
ity, specificity, PPV and NPV were 63.2% (57/87), 99.2%
(258/260), 96.5% (55/57) and 89.0% (258/347). When con-
sidering only smear-positive pulmonary specimens, the sensi-
tivity, specificity, PPV and NPV were 85.2% (46/54), 100%
(13/13), 100% (46/46) and 61.9% (13/21). When considering
only smear-negative pulmonary specimens, the sensitivity,
specificity, PPV and NPV were 27.3% (9/33), 99.2% (245/
247), 81.8% (9/11) and 91.2% (245/269).
When considering extra-pulmonary specimens, the sensi-
tivity, specificity, PPV and NPV were 59.3% (35/59), 99.1%
(541/546), 87.5% (35/40) and 95.7% (541/565). When con-
sidering only smear-positive extra-pulmonary specimens, the
sensitivity, specificity, PPV and NPV were 73.9% (16/22),
100% (12/12), 100% (16/16) and 66.7% (12/18). When con-
sidering smear-negative extra-pulmonary specimens, the
Fig. 2 Mycobacterial species identified
Table 2 Performance of culture on a total of 952 samples. PPV positive predictive value, NPV negative predictive value
Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
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sensitivity, specificity, PPV and NPV were 51.3% (19/37),
99.1% (529/534), 79.2% (19/24) and 96.7% (534/571).
These data suggest that the sensitivity and PPV of
the pan-mycobacterial are satisfying on smear-positive
specimens and limited on smear-negative specimens
especially on pulmonary smear-negative specimens
(Table 4 and Fig. 3).
Comparison of the time to diagnosis
of the pan-mycobacterial PCR
and mycobacterial culture
We next addressed the potential added-value of the direct
pan-mycobacterial PCR regarding the time to microbial
diagnostic. The median time to microbiological diagnostic
was 35 days when only culture was positive, while it was
6 days when the PCR was positive (p < 0.0001). When
considering the subgroups of slow-growing mycobacteria,
the time for identification was 35 days for culture and
6 days for the PCR (p < 0.0001), whereas for fast-
growing mycobacteria, the time for identification was
26 days for culture and 6 days for PCR (p = 0.0001)
(Table 5). When considering smear-positive and culture-
positive specimens, the time for identification of culture
and PCR was 29 days and 6 days, respectively
(p < 0.0002), whereas considering only smear-negative
and culture-positive specimens, the time for identification
of culture and PCR was 35 days and 7 days respectively
(p < 0.0001) (Table 5).
Table 3 Performance of the direct 16S rRNA gene pan-mycobacterial
PCR. The global performance of the direct 16S rRNA gene pan-
mycobacterial PCR was calculated first using culture as reference
(culture) then using clinical data to investigate discrepant results between
smear microscopy, PCR and culture (culture and clinical data). Total of
952 samples. PPV positive predictive value, NPV negative predictive
value
Reference Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)




















































Table 4 Performance of the direct 16S rRNA gene pan-mycobacterial
PCR on pulmonary and extra-pulmonary specimens using clinical data to
investigate discrepant results between smear microscopy, PCR and
culture (culture and clinical data). Total of 952 samples. PPV positive
predictive value, NPV negative predictive value
Reference Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
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Discussion
The microbiological diagnostic of nontuberculous mycobac-
terial infection has always been challenging because of the
slow growth of these organisms. In addition, some
mycobacterial species require specific growth conditions.
Thus, despite a very low limit of detection (1–10 CFU per
ml) culture may exhibit particularly limited sensitivity for
the slowest growing mycobacteria, such asM. genavense, that
may only be detected after 12-week incubation [13].
Fig. 3 Specimens localisation (number of specimens and percentage)
Table 5 Comparison of the time to diagnostic of the direct pan-mycobacterial PCR versus culture: (i) for fast- and slow-growing nontuberculous
mycobacteria and (ii) according to the initial result of the smear examination. nd no data






PCR-negative or not performed 164 35 38 18
Slow-growing NTM 145 35 39 18
Rapidly growing NTM 18 20 26 16
Mixed 1 85 85 nd
PCR-positive 30 6 7 3
Slow-growing NTM 21 6 7 3
Rapidly growing NTM 9 6 6 4
Total 194
PCR-negative or not performed 164 35 38 18
Microscopy-negative 158 35 38 18
Microscopy-positive 6 30 37 28
PCR-positive 30 6 7 3
Microscopy-negative 9 7 7 4
Microscopy-positive 21 6 7 3
Total 194
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Moreover, culture do not apply for uncultivable organisms
such as M. leprae. In the last decades, direct pan-
mycobacterial PCR allowing mycobacteria detection and
identification directly from clinical specimens have been in-
troduced to circumvent these limitations. We aimed to evalu-
ate the reliability and usefulness of the 16S rRNA gene pan-
mycobacterial PCR that we use in routine in our diagnostic
laboratory by comparing PCR with culture and microscopy
during a 10-year period (2003–2013).
This study demonstrated that using a direct pan-
mycobacterial PCR, the time to detection and identification
ofmycobacteria may be significantly reduced (29 days less) as
compared with mycobacterial culture, which may represent a
significant time saving for patient management. Despite
exhibiting a very good specificity, the pan-mycobacterial
PCR has a low sensitivity, even for smear-positive specimens
(81.8%). This limited sensitivity of the broad-spectrum PCR is
dependent on several factors as follows: (i) degenerated
primers are used in order to extend the spectrum of the PCR;
(ii) the length of the amplicon (approximately 800 base pairs)
required to precisely assign the mycobacteria at species level;
(iii) the amplicon detection methods, agarose gel chromatog-
raphy, is less sensitive than real-time PCR detection with use
of fluorescent probes; and (iv) the primers hybridise not only
16S rRNA gene from mycobacteria but also 16S rRNA gene
from other Actinobacteria (i.e. Corynebacterium sp.,
Nocardia sp., Actinomyces sp. Micrococcus sp.), which is a
problem for non-sterile specimens such as bronchial aspirates
or skin. Relying on real-time PCRmay improve the sensitivity
of the method. Thus, a pan-mycobacterial PCR based upon a
real-time PCR system will be developed ideally using both a
highly conserved target such as the 16S rRNA gene to widely
screen all mycobacteria and, in a duplex setting, using also a
more discriminant target gene such as rpoB to allow precise
identification of the most common nontuberculous
mycobacteria, which mainly include M. avium, M. kansasii
and M. chelonae/abcessus group [14]. Alternatively, multi-
plex real- t ime PCRs targeting the most common
nontuberculous mycobacteria might be reliable [15–19].
Reaching 100% of sensitivity for smear-positive specimens,
as for M. tuberculosis complex real-time PCR, would allow
applying smear-independent algorithm for the diagnosis of
NTM infections [6, 8]. Real-time PCR would also permit to
circumvent the use of nested PCR, which is proposed by some
to increase the sensitivity but which should be avoid whenever
possible because of the high risk of specimen cross-
contamination with amplicon; hence, we do not use nested-
PCR anymore since several years in our molecular diagnostic
laboratory [10, 20]. The negative predictive value reported in
this study for the pan-mycobacterial PCR (93.3%) was high
due to the low prevalence of NTM infections in this popula-
tion. Specific mycobacterial culture thus remains necessary
both for NTM detection and for subsequent phenotypic drug
susceptibility test depending on the clinical situation. The time
to identification at species level from positive culture might be
improved by new approach such as identification using pro-
tein mass-spectrometry [21].
The time to result of the pan-mycobacterial PCR was not
significantly impacted by the result of the smear examination.
This might be due to the very low sensitivity of microscopy
and the few number of smear-positive specimens. Similarly,
the limited sensitivity of the pan-mycobacterial PCR on
smear-positive specimens, might also be explained by the lim-
ited specificity of microscopy.
Our study identified 20 PCR-positive culture-negative
specimens. Among these 20 specimens, 13 were considered
true-positive based on another positive microbiological test
(other specimen PCR positive or positive smear microscopy)
or based on the clinical presentation of the patients and given
the absence of documented PCR contamination. PCR-positive
specimens with negative culture may also apply for (i)
mycobacteria difficult to cultivate such as M. genavense,
M. marinum or M. ulcerans; (ii) mycobacteria requiring spe-
cific growth conditions such as M. haemophilum; and (iii)
mycobacteria impossible to cultivate in vivo, namely
M. leprae [9, 11].
In conclusion, this study demonstrated that despite a yet
limited sensitivity, the pan-mycobacterial PCR displayed an
excellent specificity and significantly accelerated the time to
diagnostic of NTM infections. Future developments should
aim to introduce NTM real-time PCR with increased sensitiv-
ity in order to increase the detection rate and the negative
predictive value. Such a sensitive PCR would permit consid-
ering a smear-independent algorithm of mycobacterial diag-
nosis to be quicker and more sensitive and less operator-
dependent.
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